Nanofactories for Controlled Synthesis and Delivery of Nucleoside Analogue Therapeutics

Kourosh H. Ebrahimi*

*Corresponding author for this work

Research output: Contribution to journalComment/debatepeer-review

1 Citation (Scopus)


The ultimate nanomedicine will be a cell-like machinery capable of reaching a specific target in the body and performing a desired therapeutic action in a controlled fashion. To make such machinery a reality, we need to combine fundamental knowledge and technological developments in different areas including polymer chemistry, biology, enzymology, and biochemical engineering. In this viewpoint, I put forward my vision of creating a nanofactory as a step towards developing cell-like nanomedicines. To make the proposed nanofactory a reality there are many challenges ahead. I propose plausible solutions to address some of the main challenges.

Original languageEnglish
Pages (from-to)3186-3188
Number of pages3
JournalChembiochem : a European journal of chemical biology
Issue number22
Publication statusPublished - 16 Nov 2020


  • Animals
  • Drug Delivery Systems
  • Humans
  • Nanomedicine
  • Nucleosides/chemical synthesis


Dive into the research topics of 'Nanofactories for Controlled Synthesis and Delivery of Nucleoside Analogue Therapeutics'. Together they form a unique fingerprint.

Cite this